Stock Region Watchlist
Stock Region Watchlist For This Week 👀
Stock Region Watchlist For This Week
The stocks featured in this report were previously delivered in our trading room in real-time. To access Stock Region’s real-time trade ideas, then be sure to purchase a membership now.
Hey everyone,
Before we dive in, a quick but important reminder: This newsletter is for informational and entertainment purposes only. I’m sharing my personal watchlist and my thoughts on these stocks. This is NOT financial advice. Always do your own research and consult with a professional before making any investment decisions.
Now, let’s get to the good stuff. It’s been an interesting market, and I’ve got a few names on my radar this week that are telling some very different stories.
Today’s Watchlist:
Uber Technologies ($UBER): The Strong Gets Stronger
Sarepta Therapeutics ($SRPT): A Risky Bet on a Comeback
Palantir Technologies ($PLTR): Time for a Breather?
Norwegian Cruise Line ($NCLH): Smooth Sailing Ahead
Uber Technologies ($UBER)
Wow. Just, wow. Uber’s Q3 numbers are the kind that make you sit up and pay attention. Trips are up 22% and revenue jumped 20%. They’re not just a ride-hailing company anymore; they’re a part of our daily lives, and the financials are proving it. What really catches my eye is the 33% growth in adjusted EBITDA. That shows me they’re figuring out how to turn all that growth into actual profitability.
The stock has already run up a massive 65% this year, which can make anyone hesitant to jump in. It’s currently forming a flat base pattern, and technicians will be watching that $101.99 buy point closely. We’re watching to see if it can hold its ground. It feels like the market loves this stock right now, and the positive Q4 forecast only adds fuel to the fire.
Sarepta Therapeutics ($SRPT)
Alright, let’s talk about the complete opposite of Uber. Sarepta is a gut-wrenching story. The stock has been hammered, down almost 80% this year after its Duchenne muscular dystrophy treatment trial didn’t hit its goals. It’s the kind of news that crushes investor sentiment, and the stock chart shows it.
So why is it on my list? Because this is where high-risk, high-reward plays are born. The company isn’t giving up and plans to talk with the FDA about a different path to approval. While revenue is down, they managed to beat loss-per-share expectations, which shows they might be managing the crisis better than expected. This is not a stock for the faint of heart. this is seen as a lottery ticket right now. It could continue to bleed out, or any piece of good news could send it flying. I’m keeping it on my watchlist purely as a spectator for now.
Palantir Technologies ($PLTR)
Palantir is a fascinating one. It delivered a fantastic Q3, beating expectations and proving its financial muscle. The company has a solid, almost cult-like following among investors. Yet, the stock has pulled back recently. Some are calling it “rally exhaustion,” which is a fancy way of saying it went up too fast, too soon.
For me, this is where opportunities can pop up. When a great company’s stock takes a hit not because of bad news but because of market sentiment, it’s worth a closer look. I’m watching to see if this pullback is a healthy consolidation before the next leg up. If you’ve been waiting for an entry into Palantir, this could be a moment to start paying very close attention.
Norwegian Cruise Line ($NCLH)
It seems like everyone is ready to get back out on the open seas. The travel boom is real, and cruise lines like Norwegian are riding the wave. Strong demand and solid booking trends are painting a very positive picture for the industry.
While it doesn’t have the explosive growth story of a tech stock, there’s a certain comfort in a business benefiting from a clear, powerful consumer trend. The pent-up demand for travel is still unwinding, and that could provide a steady tailwind for NCLH. I’m watching this as a potential post-pandemic recovery play that might still have room to run as people continue to prioritize experiences.
A mix of solid growth, high risk, and steady trends. What’s on your watchlist?
Final Disclaimer: Remember, the stock market carries inherent risks. The information in this newsletter is based on my personal opinions and analysis. It is not a recommendation to buy or sell any security. You should conduct your own thorough research and make your own informed decisions. Past performance is not indicative of future results.
The pullback after running up so hard actually makes the setup more interesting from a risk reward perspective. When you combine that 121% US comercial growth with the $2.8B TCV, the fundamentals haven't changed even though sentiment cooled off. These consolidation phases after strong earnings often end up being optimal entry points for longer term holders rather than trying to chase the initial pop. The fact that it's pulling back on exhaustion rather than negative catalysts is exactly what you want to see in a quality growth name.